Lisa McClain said...

However, PBMs, it seems like, has evolved into middlemen with an outsized role in the pharmaceutical marketplace.

Context

McClain discusses the problematic evolution of pharmacy benefit managers in drug pricing.

05/22/2023

https://congress.gov...